Premier Alternatives

Mango Sciences

Boston, MA · Founded 2012 · Acquired/Merged (Operating Subsidiary)

Operator of a market data science platform intended to solve the health challenges of underrepresented populations. Mango Sciences is based in Boston, MA and was founded in 2012. Its last known valuation is $83 million (Aug 2024). It has raised $16.7 million across 1 recorded round; the latest was a $2.7 million seed round in Jan 2020.

Last price · $/share
—
Implied valuation
$83.0M
Total raised
$16.7M
Last round
Seed Round
Jan 2020

Mango Sciences key facts

  • Operator of a market data science platform intended to solve the health challenges of underrepresented populations.
  • Mango Sciences’s last known valuation is $83.0M (Aug 2024).
  • It has raised $16.7M across 1 recorded rounds; the latest was Seed Round ($2.7M) in Jan 2020.
  • Notable investors include Octopus Ventures, Realm Capital Ventures, Kube VC, Incisive Ventures, BECO Capital — 14 tracked in total.
  • Mango Sciences has filed 1 Form D with the SEC, most recently Jan 2020 ($2.7M sold to 23 investors).
  • Status: Acquired/Merged (Operating Subsidiary).
Free account
More of Mango Sciences with a free account
  • ·The complete investor list: 14 names
  • ·Watch Mango Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mango Sciences funding rounds

1 rounds
Jan 2020Seed Round$2.7MSEC filing▮
Full funding history →

Mango Sciences valuation

Mango Sciences's last known valuation is $83 million, from Aug 2024. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Mango Sciences raised?

Mango Sciences has raised $16.7 million in total; 1 of its rounds is on record. The largest on record was a $2.7 million seed round in Jan 2020.

Mango Sciences has filed 1 Form D with the SEC, most recently in Jan 2020 ($2.7 million sold to 23 investors).

Mango Sciences investors

14 investors are on record for Mango Sciences, including Octopus Ventures, Realm Capital Ventures, Kube VC and Incisive Ventures. The seed round in Jan 2020 drew 23 investors.

About Mango Sciences

Operator of a market data science platform intended to solve the health challenges of underrepresented populations. The company's platform utilizes artificial intelligence analytics to transform deep clinical data into key insights and real-world evidence, improve access to life-saving care, and identify patients for clinical trials, enabling patients to have value-based financing agreements for immunotherapy drugs in emerging markets.

Sector
Information Technology
HQ
Boston, MA, United States
Founded
2012
Employees
48
Ownership
Acquired/Merged (Operating Subsidiary)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$83.0M

Mango Sciences’s last known valuation, Aug 2024. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.